NCT07299331 2025-12-23
Zanubrutinib, Rituximab, and Lenalidomide in the First-Line Treatment of Marginal Zone Lymphoma
Zhengzhou University
Phase NA Not yet recruiting
Clinical Trials
4 trialsNCT07071246 2025-07-17
Rituximab for the Treatment of New-onset AChR-Myasthenia Gravis
Tang-Du Hospital
Phase NA Active not recruiting
NCT01829958 2025-05-06
Comprehensive Geriatric Assessment to Predict Toxic Events in Older Patients With Non-Hodgkin Lymphoma With Imbedded Pilot Study of Pre-Phase Therapy
Memorial Sloan Kettering Cancer Center
Phase NA Active not recruiting
NCT06942507 2025-04-30
BRZ-WM
Peking Union Medical College Hospital
Phase NA Not yet recruiting